Headlines

Algorithm Plots Efficient Course for Assessing Immune-related Adverse Events in Cancer Immunotherapy

Algorithm Plots Efficient Course for Assessing Immune-related Adverse Events in Cancer Immunotherapy

Use of a collaborative team dedicated to managing immune-related adverse events (irAEs) enabled prompt recognition and safe, successful management in patients receiving immunotherapy for cancer.

Nurses Can Minimize, Prevent Complications of Abdominal Compartment Syndrome

Nurses Can Minimize, Prevent Complications of Abdominal Compartment Syndrome

The oncology nurse plays a pivotal role in the management of abdominal compartment syndrome (ACS) by focusing on risk assessment and early identification of clinical signs and symptoms.

MASCC Tool Improves Documentation of Dermatologic Toxicities of TKIs

MASCC Tool Improves Documentation of Dermatologic Toxicities of TKIs

Incorporating a modified MASCC grading tool for evaluating epidermal growth factor receptor inhibitor (EGFRI) toxicities and quality of life improved the rate of skin assessments and documentation.

Oncology Nurses Ideal for Educating Patients on Portal Vein Thrombosis

Oncology Nurses Ideal for Educating Patients on Portal Vein Thrombosis

Oncology nurses are in an ideal position to educate patients with gastrointestinal malignancies and PVT about risk factors, clinical presentation, complications, and treatment options to prevent further extension of the clot.

Study Suggests Clinicians Can Use Opioid of Choice for Breakthrough Cancer Pain

Study Suggests Clinicians Can Use Opioid of Choice for Breakthrough Cancer Pain

All opioids are currently recommended for breakthrough cancer pain and clinicians may use the opioid of their choice.

Nursing Considerations Regarding Fentanyl Sublingual Spray Titration

Nursing Considerations Regarding Fentanyl Sublingual Spray Titration

Treatment of breakthrough cancer pain is an important component of care for patients, and nurses should consider various factors when titrating the dose of fentanyl sublingual spray to an effective dose.

Programs for Lay Health Advisors Can Be Designed to Maximize Their Impact

Clear role expectations and organization support are vital for lay health advisors.

Nivolumab Shows Promise Against Aggressive Anal Cancer

Clinical trial results are promising for the use of nivolumab to treat squamous cell carcinoma of the anal canal, according to data presented at the 2016 American Association for Cancer Research Annual Meeting.

Targeting Drugs to Pancreatic Cancer Through Implantable Device

New research indicates a far greater efficacy in pancreatic cancer drug therapy delivered via implantable device than via IV.

Risk-specific Prevention Strategies Effectively Reduce Falls on Malignant Hematology Unit

Risk-specific Prevention Strategies Effectively Reduce Falls on Malignant Hematology Unit

High-risk medications can increase falls in patients undergoing treatment for malignant hematology, but implementing risk-specific fall prevention strategies can ameliorate the effects of the drugs.

Conference Coverage

Algorithm Plots Efficient Course for Assessing Immune-related Adverse Events in Cancer Immunotherapy

Use of a collaborative team dedicated to managing immune-related adverse events (irAEs) enabled prompt recognition and safe, successful management in patients receiving immunotherapy for cancer.

Nurses Can Minimize, Prevent Complications of Abdominal Compartment Syndrome

The oncology nurse plays a pivotal role in the management of abdominal compartment syndrome (ACS) by focusing on risk assessment and early identification of clinical signs and symptoms.

MASCC Tool Improves Documentation of Dermatologic Toxicities of TKIs

Incorporating a modified MASCC grading tool for evaluating epidermal growth factor receptor inhibitor (EGFRI) toxicities and quality of life improved the rate of skin assessments and documentation.

Oncology Nurses Ideal for Educating Patients on Portal Vein Thrombosis

Oncology nurses are in an ideal position to educate patients with gastrointestinal malignancies and PVT about risk factors, clinical presentation, complications, and treatment options to prevent further extension of the clot.

Study Suggests Clinicians Can Use Opioid of Choice for Breakthrough Cancer Pain

All opioids are currently recommended for breakthrough cancer pain and clinicians may use the opioid of their choice.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs